These GLP-1 receptor agonists work by helping regulate body weight, reducing appetite, and supporting a healthy, reduced-calorie diet
, : Rising global prevalence of obesity and diabetes Strong clinical success of GLP-1 receptor agonists Growing investments from leading pharmaceutical companies Expansion into cardiovascular and metabolic health indications Increasing demand for effective long-term weight management solutions Breakthrough therapies from global innovators are reshaping how metabolic diseases are managed
People who take regular doses of semaglutide or tirzepatide (another active ingredient in some GLP-1 meds) can buy the brand-name drugWegovy, Ozempic, Zepbound, Mounjarothrough a regular pharmacy, if covered by health insurance, or directly from the manufacturer
This observation led them to speculate that GLP-1 analogs might possess distinct neurotrophic properties and exert protective effects specifically on the nerve
That means: No dependency on ongoing chemical injections